Dr. Mary K. Reed, MD, FACP

Media Releases

Get to know Hematologist-Oncologist Dr. Mary K. Reed, who serves patients in Queens, New York.

An established hematologist-oncologist, Dr. Reed is in practice at NYC Health + Hospitals / Queens.

NYC Health + Hospitals / Queens is part of New York City’s public health care system, proudly serving the culturally diverse communities of central and southeastern Queens. Since its opening in 1935, the mission of NYC Health + Hospitals/Queens has been to provide quality, comprehensive care to all, regardless of their ability to pay.

Back in 1980, Dr. Reed earned her medical degree from the Boston University School of Medicine. She then went on to complete her residency in internal medicine at the Henry Ford Hospital in 1983, and her fellowship in hematology and medical oncology at the Zucker School of Medicine at Hofstra/Northwell in 1987.

Recognized as a Fellow of the American College of Physicians (FACP), the doctor attained board certification in hematology, medical oncology, hospice & palliative medicine, and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, sickle-cell disease, and a rare hematologic related syndromes, and diseases.

Recommended Articles

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Treatments for Multiple Myeloma

  The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...

• Roles of the National Coalition for Cancer Survivorship

  The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...

• Life Lessons After Multiple Misdiagnoses of Lymphoma

  28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...

• How Dogs Are Helping with Lymphoma Research

  According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...